BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 10691142)

  • 1. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
    Esser D; Anke S; Roessner A; Freigang B
    Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
    Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
    Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.
    Cheng L; Sebo TJ; Cheville JC; Pisansky TM; Slezak J; Bergstralh EJ; Pacelli A; Neumann RM; Zincke H; Bostwick DG
    Cancer; 1999 Mar; 85(6):1293-9. PubMed ID: 10189134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.
    Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H
    Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor biologic prognostic parameters in T1N0M0 squamous cell carcinoma of the oral cavity].
    Welkoborsky HJ; Gluckman JL; Jacob R; Bernauer H; Mann W
    Laryngorhinootologie; 1999 Mar; 78(3):131-8. PubMed ID: 10226980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 expression predicts radiosensitivity in oral squamous cell carcinoma.
    Freudlsperger C; Freier K; Hoffmann J; Engel M
    Int J Oral Maxillofac Surg; 2012 Aug; 41(8):965-9. PubMed ID: 22591716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression, proliferation marker Ki-S5, DNA content and serum PSA: possible biopotential markers in human prostatic cancer.
    Papadopoulos I; Rudolph P; Wirth B; Weichert-Jacobsen K
    Urology; 1996 Aug; 48(2):261-8. PubMed ID: 8753738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
    Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
    Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
    J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas.
    Golouh R; Bracko M; Novak J
    Mod Pathol; 1996 Sep; 9(9):919-24. PubMed ID: 8878024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy.
    Kokoska MS; Piccirillo JF; el-Mofty SK; Emami B; Haughey BH; Schoinick SB
    Cancer; 1996 Oct; 78(8):1693-700. PubMed ID: 8859182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
    Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N
    Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation induced early nuclear changes in cytologic brush specimens from the upper aerodigestive tract.
    Ambrosch P; Ruschenburg I
    In Vivo; 2000; 14(6):757-60. PubMed ID: 11204495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P; Adelstein DJ; Myles J; Secic M
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.